NVCHI
NVS icon

New Vernon Capital Holdings II’s Novartis NVS Stock Holding History

New Vernon Capital Holdings II’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Sell
14,733
-2,178
-13% -$334K 1.66% 15
2025
Q4 		$2.33M Hold
16,911
– – 1.11% 20
2025
Q3 		$2.17M Hold
16,911
– – 1% 23
2025
Q2 		$2.05M Sell
16,911
-1,366,333
-99% -$154M 0.98% 22
2025
Q1 		$12.4M Buy
1,383,244
+1,372,407
+12,664% +$146M 0.28% 30
2024
Q4 		$1.05M Sell
10,837
-2,527
-19% -$269K 0.73% 14
2024
Q3 		$1.54M Buy
+13,364
New +$1.52M 0.83% 17

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New Vernon Capital Holdings II's NVS Position: Q1 2026 in Review

New Vernon Capital Holdings II reduced its Novartis (NVS) stake by 13% in Q1 2026, selling an estimated $334K and leaving 14,733 shares worth $2.25M. The position accounts for 1.66% of the portfolio, ranked #15.

New Vernon Capital Holdings II first reported a position in NVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $12.4M in Q1 2025. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • New Vernon Capital Holdings II held 14,733 shares of Novartis worth $2.25M as of Q1 2026.
  • New Vernon Capital Holdings II sold 2,178 Novartis shares in Q1 2026, an estimated $334K.
  • Novartis made up 1.66% of New Vernon Capital Holdings II's portfolio in Q1 2026, its #15 holding.
  • New Vernon Capital Holdings II first reported a position in Novartis in Q3 2024 and has held it in 7 quarters since.
  • New Vernon Capital Holdings II's Novartis position peaked at $12.4M in Q1 2025.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2026, filed 15 May 2026.